논문KCI 등재
Correspondence to editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (9)
관련 논문AI추천
Screening of patients at high risk of de novo recurrence in HCC: Editorial on “Exploring methylation signatures for high de novo recurrence risk in hepatocellular carcinoma”Ping Huang, Rui Liao, Shiqiao Luo대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”Hyo Jung Cho, Su Bin Lim대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence to editorial on “Molecular classifica tion of hepatocellular carcinoma based on zoned met abolic feature and oncogenic signaling pathway”Masatoshi Kudo, Naoshi Nishida, Tomoko Aoki대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호Correspondence to editorial on “Conventional and machine learning-based risk scores for patients with early- stage hepatocellular carcinoma”Chien-Wei Su, Chun-Ting Ho, Elise Chia-Hui Tan대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Correspondence to editorial on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”Fan Peng, Jinliang Xing, Siyuan Wang, Yang Liu대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma”Chien-Wei Su, Chun-Ting Ho, Elise Chia-Hui Tan대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호
이 간행물의 다른 논문 (84건)
Epidemiology of metabolic dysfunction-associated steatotic liver diseaseLinda Henry, Markos Kalligeros, Zobair M. Younossipp. 32-50Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver diseaseJimmy Che-To Lai, Sherlot Juan Song, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Grace Lai-Hung Wong, Yichong Jiang, Yue Wangpp. 51-75Precision medicine and nucleotide-based therapeutics to treat steatotic liver diseaseAndrea Caddeo, Stefano Romeopp. 76-93Microbiome-centered therapies for the management of metabolic dysfunction-associated steatotic liver diseaseJasmohan S. Bajaj, Jeremy Burton, Antonio Gil-Gómez, Huma Saeed, Juan Pablo Arab, Luis Antonio Díaz, Manuel Romero-Gomez, Marco Arrese, Mohammad Qasim Khanpp. 94-111Alcohol-associated liver disease: Natural history, management and novel targeted therapiesHugo López-Pelayo, Edilmar Alvarado-Tapias, Ana Clemente-Sánchez, Ramón Bataller, Jordi Gratacós-Ginès, Elisa Posepp. 112-133